Sulfasalazine induced agranulocytosis treated with granulocyte-macrophage colony stimulating factor.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 1350640.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We report the use of granulocyte-macrophage colony stimulating factor (GM-CSF) in a case of rheumatoid arthritis with sulfasalazine induced agranulocytosis, leading to a rapid bone marrow recovery within 7 days. This case and 2 others reported in the literature emphasize the need for further research into the possible role of GM-CSF in the treatment of drug induced agranulocytosis.
Medical subject headings
- Agranulocytosis
- Granulocyte-Macrophage Colony-Stimulating Factor
- Sulfasalazine